Study Questions Routine Long-term Beta-Blocker Post MI Study Questions Routine Long-term Beta-Blocker Post MI
Long-term beta-blocker therapy prescribed after an acute MI might be obsolete in the modern reperfusion era, according to an analysis of Danish registry data.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

DAPA-CKD: SGLT2 Inhibitors'The Beta-Blockers for the Kidneys'DAPA-CKD: SGLT2 Inhibitors'The Beta-Blockers for the Kidneys '
Nephrologists Jennie Lin and Leslie Gewin discuss the effects of dapagliflozin in patients with CKD. How do the DAPA-CKD findings fit with the CREDENCE data on SGLT2 inhibitors?Medscape Nephrology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 4, 2020 Category: Intensive Care Tags: Nephrology Commentary Source Type: news

RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF
Study results show equally good rate control with digoxin as with a beta-blocker, but with far fewer adverse events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 31, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Nine Antihypertensive Drugs Associated With Reduced Risk for Depression Nine Antihypertensive Drugs Associated With Reduced Risk for Depression
A 2005-2015 study found reduced risk for depression in angiotensin agents (ACE inhibitors or angiotensin II receptor blockers), calcium antagonists, beta-blockers, and diuretics.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 27, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Antihypertensive Agents Not Tied to Higher Risk for Depression
MONDAY, Aug. 24, 2020 -- Nine individual antihypertensive agents from the classes of angiotensin agents, calcium antagonists, andβ-blockers are associated with reduced rates of depression, according to a study published online Aug. 24 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 24, 2020 Category: Pharmaceuticals Source Type: news

COX2 Inhibitor and Beta Blocker Combo to Reduce CRC Metastasis? COX2 Inhibitor and Beta Blocker Combo to Reduce CRC Metastasis?
Used perioperatively, the combination significantly improved biomarkers of malignancy and resulted in a lower recurrence rate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Medications May Drive Postmenopausal Weight Gain Medications May Drive Postmenopausal Weight Gain
Use of weight-promoting medications such as antidepressants, beta-blockers, insulin, and glucocorticosteroids may contribute to postmenopausal abdominal weight gain, data from the Women's Health Initiative indicate.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 24, 2020 Category: Psychiatry Tags: Diabetes & Endocrinology News Source Type: news

Prior Beta Blockers Predict Extra HF Burden in Women With ACS Prior Beta Blockers Predict Extra HF Burden in Women With ACS
Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 15, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Medication Use Linked to Weight Gain in Postmenopausal Women
Use of antidepressants, beta - blockers, insulin linked to increase in BMI, waist circumference (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 15, 2020 Category: Psychiatry Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news

Medication Use Linked to Weight Gain in Postmenopausal Women
WEDNESDAY, July 15, 2020 -- For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years, according to a study published online July 15 in Menopause. Fatima Cody Stanford, M.D., M.P.H., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2020 Category: Pharmaceuticals Source Type: news

How much postmenopause weight gain can be blamed on weight-promoting medications?
(The North American Menopause Society (NAMS)) Abdominal weight gain, which is common during the postmenopause period, is associated with an array of health problems, including diabetes and heart disease. A new study suggests that the use of antidepressants, beta-blockers, and insulin during the menopause transition is partially to blame for such unhealthy weight gain. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2020 Category: International Medicine & Public Health Source Type: news

Beta Blocker Heart Meds Pose Special Risks
Title: Beta Blocker Heart Meds Pose Special RisksCategory: Health NewsCreated: 7/13/2020 12:00:00 AMLast Editorial Review: 7/14/2020 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - July 14, 2020 Category: Cardiology Source Type: news

Beta blockers may increase heart failure risk in women, study finds
Women who take beta blockers for high blood pressure are at nearly 5 percent higher risk for heart failure than men, even if they have no history of heart disease, according to a study published Monday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 13, 2020 Category: Consumer Health News Source Type: news

Beta Blocker Heart Meds Might Pose Special Risks for Women
MONDAY, July 13, 2020 -- Millions of Americans are prescribed blood pressure medicines called beta blockers, especially after a heart attack. But a new Italian study finds that these go-to drugs might not work as well for women as they do for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 13, 2020 Category: General Medicine Source Type: news

Risk for Heart Failure Increased for Women Taking β-Blockers
MONDAY, July 13, 2020 -- Women takingβ-blockers for hypertension have an increased risk for developing heart failure when they present to the hospital with acute coronary syndrome, according to a study published online July 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2020 Category: Pharmaceuticals Source Type: news

What if we could design powerful drugs without unwanted side effects?
(Stanford School of Engineering) The paper describes how to minimize or eliminate side effects in drugs that target G protein-coupled receptors. GPCRs are proteins found in all human cells. LSD and other psychedelics are molecules that attach to GPCRs, as are about a third of prescription drugs, including antihistamines, beta blockers and opioids. 'Armed with our results, researchers can begin to imagine new and better ways to design drugs that retain their effectiveness while posing fewer dangers.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2020 Category: International Medicine & Public Health Source Type: news

Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality after Sepsis:
Antagonists of the renin-angiotensin-aldosterone system (RAAS), including ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers), may prevent organ failure. We, therefore, investigated whether specific RAAS inhibitors are associated with reduced mortality in patients with sepsis.We conducted a population-based retrospective cohort study using multivariable propensity score-based regression to control for differences among patients using different RAAS inhibitors. A multivariable-adjusted Cox proportional-hazards regression model was used to determine the association between RAAS inhibi...
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

Combining antidepressants with beta-blockers: evidence of a clinically significant CYP2D6 drug interaction - Shin J, Hills NK, Finley PR.
BACKGROUND: Beta-blockers and antidepressants are two of the most commonly prescribed drug classes in the United States. Several antidepressants are potent inhibitors of cytochrome P450 2D6 liver enzymes (CYP2D6) and can increase the plasma concentrations ... (Source: SafetyLit)
Source: SafetyLit - May 2, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Landiolol Effective for Sepsis-Related Tachyarrhythmias Landiolol Effective for Sepsis-Related Tachyarrhythmias
The ultra-short-acting beta blocker landiolol safely and effectively treated sepsis-related tachyarrhythmias in its first open-label randomized controlled trial, held in Japan.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 14, 2020 Category: Intensive Care Tags: Critical Care News Source Type: news

What Causes Tachycardia?
Discussion Tachycardia is a rapid heart rate that is above normal for age and level of exertion. Tachycardia is common, particularly sinus tachycardia due to normally encountered circumstances such as pain, fever or exercise. It is usually a normal physiologic process but sustained tachycardia often indicates a potentially abnormal underlying cause. Sinus tachycardia has a rapid heart rate with normal P waves and P-R intervals and variations from moment to moment and respiration. Generally it is not over 200 beats/minute. Vagal stimulation can slow the heart rate; this is a gradual slowing, not an abrupt slowing seen in ...
Source: PediatricEducation.org - March 23, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Prognosis of beta-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies
Purpose: beta-adrenoceptor antagonist (beta-blocker) may have potential in the treatment of septic shock and sepsis. However, the relevant research findings are still controversial. Method(s): We conducted a systematic review and meta-analysis to explore the efficacy of beta-blocker in patients with septic shock and sepsis. The primary sources of the reviewed studies through August 2018, with restriction on the language of English, were Pubmed and Embase. Randomized controlled trials (RCT) were included to evaluate the efficacy of beta-blocker in the treatment of septic shock and sepsis. Meta analysis was performed using a...
Source: Current Awareness Service for Health (CASH) - March 13, 2020 Category: Consumer Health News Source Type: news

Going Off Beta Blockers as an Option in Selected Low-Risk LQTS Going Off Beta Blockers as an Option in Selected Low-Risk LQTS
They are guideline-recommended for all patients with long-QT syndrome, but beta blockers may not be needed in some who are at exceptionally low risk and feel disabled by their side effects, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 9, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Overcoming Agoraphobia
Anxiety and agoraphobia are two of the most searched for terms related to mental health in the UK. On average the two terms are searched for 122,000 times a month on Google suggesting a large need for help with this area. Agoraphobia is typically found in up to 3% of the population. Mainly people aged 20-30 with it being twice as prevalent in women. But anyone can suffer from this regardless of age, sex or gender. Under the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders, agoraphobia is defined as a condition where individuals have a disproportionate fear of public places. People often see environm...
Source: Psych Central - February 24, 2020 Category: Psychiatry Authors: Gregory Warwick, DCounsPsych, CPsych, AFBPsS Tags: Agoraphobia Anxiety Panic Disorder Exposure Therapy Panic Attack Source Type: news

Clinicians in the dark about potential harms of commonly prescribed beta blocker
Better understanding needed to stave off overdose deaths, warns HSIB Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Too few women take part in many CVD clinical trials Pharmacists could offer high-dose statins direct to patients Cannabinoids not recommended to treat cancer-related pain GPs defend practice on prescribing statins (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 19, 2020 Category: UK Health Source Type: news

Timing of b-Blocker Reintroduction and AF After Cardiac Surgery Timing of b-Blocker Reintroduction and AF After Cardiac Surgery
Does the timing of timing of beta-blocker reintroduction after cardiac surgery impact its effectiveness on the incidence of postoperative atrial fibrillation?Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Medications May Lower Risk Of ‘ Broken Heart ’ After Loss Of Loved One, Study Says
In this study, researchers at the University of Sydney looked at 85 spouses or parents grieving the loss of a family member. They found that those who received low doses of a beta blocker and aspirin for the first six weeks had lower spikes in blood pressure and heart rates and improvements in the tendency to form blood clots. They also had less symptoms of anxiety and depression. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 12, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall Source Type: news

Beta-Blockers, ACE Inhibitors Don ’ t Raise Anaphylaxis Risk From Cardiac Catheterization Beta-Blockers, ACE Inhibitors Don ’ t Raise Anaphylaxis Risk From Cardiac Catheterization
The risk of anaphylactic reactions from contrast media used during cardiac catheterization is not increased in patients on beta-blockers or angiotensin-converting enzyme (ACE) inhibitors, according to results from a retrospective case-control study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - December 20, 2019 Category: Radiology Tags: Cardiology News Source Type: news

Study Casts Doubt on Use of Common Heart Failure Drugs
THURSDAY, Dec. 5, 2019 -- Millions of Americans with heart failure take one of the family of beta blocker medications to help ease the condition. But in many cases, could the meds be doing more harm than good? A new study found that taking beta... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2019 Category: General Medicine Source Type: news

DAPA-HF: Heart Failure Toolbox Poised to Add New Drug Family DAPA-HF: Heart Failure Toolbox Poised to Add New Drug Family
' What I don't want to see is slow uptake, once it gets the indication in nondiabetics,'said one physician. Think of SGLT2 inhibitors the same way as ACE inhibitors, beta blockers, and other HF drugs.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 19, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review
The effect of premorbid β-blocker exposure on clinical outcomes in patients with sepsis is not well characterized. We aimed to examine the association between premorbid β-blocker exposure and mortality in sepsis. This systematic review suggests that β-blocker exposure prior to sepsis is associated with reduced mortality . There was insufficient data to conduct a bona fide meta-analysis. Whether the apparent reduction in mortality may be attributed to the mitigation of catecholamine excess is unclear. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Beta Blocker Fails to Shorten Time to First COPD Exacerbation Beta Blocker Fails to Shorten Time to First COPD Exacerbation
A new randomized placebo-controlled trial that was halted early for safety reasons has failed to confirm observational studies suggesting that beta-blockers reduce exacerbations in moderate or severe chronic obstructive pulmonary disease (COPD).Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 23, 2019 Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news

Safety of Non-selective b-Blockers in Decompensated Cirrhosis Safety of Non-selective b-Blockers in Decompensated Cirrhosis
Treatment with non-selective beta blockers in patients with decompensated cirrhosis and ascites remains controversial. What factors might contribute to adverse events?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Blood Pressure Med May Improve Cognitive Impairment in Autism Blood Pressure Med May Improve Cognitive Impairment in Autism
This study suggests that using beta-blockers might be a promising approach.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 26, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

STOP-CRT: Maybe Stop Some HF Meds if CRT Restores Heart Function STOP-CRT: Maybe Stop Some HF Meds if CRT Restores Heart Function
It's only one study, but some highly selected patients might improve on cardiac resynchronization therapy such that RAAS inhibitors and beta blockers are no longer indicated, a researcher says.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Medical News Today: Beta-blockers for anxiety: What to know
Beta-blockers are a type of medication that can treat heart conditions. Some doctors also prescribe them to ease the symptoms of anxiety. Learn more in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2019 Category: Consumer Health News Tags: Anxiety / Stress Source Type: news

Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF
Use of guideline-recommended meds started out high after CABG but waned over time in a registry study that, controversially, also saw no survival benefit to long-term postoperative beta blockers.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 12, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Indications for Beta-Blocker Prescriptions in HFpEF Indications for Beta-Blocker Prescriptions in HFpEF
Are beta-blockers being unnecessarily prescribed for older adults with heart failure with preserved ejection fraction, despite little evidence of their benefit?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2019 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Gallstone sufferers may one day avoid surgery thanks to new discovery
Scientists from University Hospital Erlangen, Germany, discovered the 'established' beta-blocker metoprolol blocked the growth of gallstones in mice with the painful condition. (Source: the Mail online | Health)
Source: the Mail online | Health - August 15, 2019 Category: Consumer Health News Source Type: news

When Might Post-MI Beta-Blockers Be Safely Deprescribed? When Might Post-MI Beta-Blockers Be Safely Deprescribed?
If an older patient is ischemia-free on beta-blockers 3 years later, he or she doesn't seem to confer further protection over the next 5 years, suggests data from an admittedly older registry.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 17, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Another Use for Beta Blockers? Curbing A-fib
Title: Another Use for Beta Blockers? Curbing A-fibCategory: Health NewsCreated: 6/4/2019 12:00:00 AMLast Editorial Review: 6/5/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 5, 2019 Category: Cardiology Source Type: news

Beta Blockers Might Fight A-Fib Too
A-fib is a common heart rhythm disorder sometimes triggered by stress and negative emotions. Beta blockers are drugs that block the effects of adrenaline and related substances. (Source: WebMD Health)
Source: WebMD Health - June 4, 2019 Category: Consumer Health News Source Type: news

Beta-Blockers May Moderate Impact of Stress on Atrial Fibrillation
TUESDAY, June 4, 2019 -- β-blockers can attenuate the impact of anger or stress on atrial fibrillation (AF), according to a study published online June 4 in HeartRhythm. Rachel Lampert, M.D., from the Yale University School of Medicine in New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2019 Category: Pharmaceuticals Source Type: news

Another Use for Beta Blockers? Curbing A-fib
TUESDAY, June 4, 2019 -- People whose heart rhythm problems stem from stress and anger may benefit from taking beta blocker drugs, a new study suggests. Atrial fibrillation (a-fib) is a common type of heart rhythm disorder sometimes triggered by... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2019 Category: General Medicine Source Type: news

Beta blockers reduce stress-induced irregular heart rhythm
The strategy of taking beta blockers could potentially improve quality of life for many of the two million Americans with the condition. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 4, 2019 Category: Universities & Medical Training Source Type: news

Beta blockers reduce stress-induced irregular heart rhythm
(Yale University) Taking beta blockers -- medications that reduce blood pressure and treat many heart conditions -- can blunt the negative effects of stress and anger on people with a history of atrial fibrillation, or irregular heart rhythm, said Yale researchers. This strategy could potentially improve quality of life for many of the 2 million Americans with the condition, according to a new study. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 4, 2019 Category: International Medicine & Public Health Source Type: news

Heart Patients at Risk When Pharmacies Close
MONDAY, May 13, 2019 -- When pharmacies close, people with heart disease stop taking widely used heart medications, such as statins, beta-blockers, and oral anticoagulants, according to a study published online April 19 in JAMA Network Open. Dima M.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2019 Category: Pharmaceuticals Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
The effect was found only with atenolol (Tenormin). Two other beta blockers -- metoprolol (Lopressor/Toprol XL) and carvedilol (Coreg) -- did not appear to provide any protection against prostate cancer. (Source: WebMD Health)
Source: WebMD Health - May 3, 2019 Category: Consumer Health News Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
FRIDAY, May 3, 2019 -- Good news for men: That blood pressure medication you're taking might be doing double duty, helping reduce your risk of developing prostate cancer, a new study shows. Researchers found that a beta blocker called atenolol cut... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 3, 2019 Category: General Medicine Source Type: news

Adherence to CV Meds Suffers When Pharmacies Shut Down for Good Adherence to CV Meds Suffers When Pharmacies Shut Down for Good
Patients fall behind on their statins, beta blockers, and oral anticoagulants when pharmacies close, but there are opportunities for health policy, payers, and pharmacies themselves to help.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

ECG Challenge: Why Is His Pulse so Slow? ECG Challenge: Why Is His Pulse so Slow?
A man taking a beta-blocker presents with a pulse of 48 beats/min. What does his ECG show?Medscape Cardiology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology Clinical Case Source Type: news